Our factory

Travelers' Map is loading...
If you see this after your page is loaded completely, leafletJS files are missing.

Invented and Formulated in Switzerland – Developed and Manufactured in France.

We believe that rooting in a territory brings stability, trust and cohesion. We have chosen to set up SyrHAtech in the heart of the mountains, between the Canton of Geneva, the Pays de Savoie and the Lyon Region.

SyrHA is organized into 3 distinct sites, each with its own specificity, drawing from its terroir the qualities that are essential to it.
These three sites benefit from Franco-Swiss know-how for the development of high-performance products and optimized manufacturing techniques.
  • SWITZERLAND / Plan-les-Ouates

    The company's headquarters and laboratory are located in the canton of Geneva and thus benefit from Swiss rigor and quality for the development of its formulas. The prototyping stage of our formulas is carried out on site, as well as the manufacture of pre-series.
  • FRANCE / l'Arbresle

    Between Lyon and Roanne, we manufacture small series, once the prototyping and pre-series stage have been completed. This manufacturing site allows a product launch with low validation costs.
  • FRANCE / Sainte Hélène du Lac

    Between Chambéry and Albertville, we are moving to the next level: large scale industrial production. It is from this production site that your products will come out in an optimized batch size. It is also the site for the development of innovative manufacturing technologies to prepare the formulations of tomorrow.

Explore our environment

  • Company

    They Trust SyrHA : The Excellence of a CDMO

    At SyrHA, we believe that the cornerstone of our success is the unwavering trust that…

    Clients testimonials
  • Company

    Announcing strategic partnership : SyrHA the CDMO and ISHAS organization

    We are pleased to inform you that SyrHA has joined the International Society for Hyaluronic…

  • Company

    CDMO: Evolution of their role

    Innovative biopharmaceutical companies are increasingly engaging in strategic partnerships with CDMOs, whereas in the past,…

    CDMO: Evolution of their role
  • Company

     Join us at IMCAS Paris! 

    We’re delighted to announce that our team will be taking part in the IMCAS 2024…

    IMCAS 2024 World Congress in Paris
  • Company

    SyrHATech is thrilled to install its new autoclave!

    In the field of sterile medical device manufacturing, the terminal sterilization of your products is…

    SyrHATech new autoclave
  • Company

    SyrHATech goes to CPHI Barcelona – from 10/24 to 10/26

    The CPHI (Convention on Pharmaceutical Ingredients) is the reference event for the pharmaceutical industry. Itinerant…

    CPHI Barcelona 2023
  • Company

    Inauguration of Syrhatech’s new premises in Geneva

    The Syrhatech team was delighted to share a convivial moment on its terrace on the…

    Inauguration of Syrhatech's new premises in Geneva
  • Company

    Development of a specific syringe for wrinkle filler

    Our customer contacts us to validate the design of a syringe made of plastic by…

  • Company

    Development of an innovative gel with very high concentration

    Our client contacts us to industrialize a new manufacturing technique, compatible with the objectives of…

  • Company

    Technology transfer

    Our team relies on its many years of experience and past successes, to prepare and…

    Syrhatech - technology transfer